These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23243924)

  • 1. [Gamma-hydroxybutyrate (GHB) and its lactone (GBL) as psychoactive substances].
    Krajewska A; Kwiecień-Obara E; Szponar J; Majewska M; Kołodziej M
    Przegl Lek; 2012; 69(8):544-7. PubMed ID: 23243924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.
    Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM
    Toxicol Lett; 2017 Aug; 277():84-91. PubMed ID: 28579487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
    Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
    QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
    Wood DM; Brailsford AD; Dargan PI
    Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute gamma-butyrolactone poisoning with withdrawal syndrome].
    Chwaluk P; Rejmak G
    Przegl Lek; 2011; 68(8):537-8. PubMed ID: 22010460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
    Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H
    Drug Alcohol Depend; 2006 Feb; 81(3):323-6. PubMed ID: 16143455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [First report of lethal gamma-hydroxybutyrate (GHB) intoxication after consumption of gamma-butyrolactone (GBL) in Lower Saxony].
    Fieguth A; Albrecht K; Weller JP; Kühnle R; Teske J
    Arch Kriminol; 2009; 223(1-2):45-51. PubMed ID: 19323150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-hydroxybutyrate--a drug of abuse.
    Drasbek KR; Christensen J; Jensen K
    Acta Neurol Scand; 2006 Sep; 114(3):145-56. PubMed ID: 16911342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GHB--dangerous, addictive and uncontrollable "party drug"].
    Persson SA; Eriksson A; Hallgren N; Eklund A; Berkowicz A; Druid H
    Lakartidningen; 2001 Sep; 98(38):4026-31, 4033-5. PubMed ID: 11602959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gamma-hydroxybutyrate--an endogenous substance and a new central nervous system stimulant. Clinical aspects of acute poisoning].
    Engelsen J; Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6903-7. PubMed ID: 10643375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abuse of γ-hydroxybutyrate].
    Bramness JG; Haugland S
    Tidsskr Nor Laegeforen; 2011 Nov; 131(21):2122-5. PubMed ID: 22048208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extreme γ-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis.
    Roberts DM; Smith MW; Gopalakrishnan M; Whittaker G; Day RO
    Ann Emerg Med; 2011 Jul; 58(1):83-5. PubMed ID: 21435738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [GHB, GBL and butanediol poisonings--a serious problem in Western Sweden].
    Knudsen K; Greter J; Verdicchio M; Cederquist T
    Lakartidningen; 2005 Nov 7-13; 102(45):3294-6, 3299. PubMed ID: 16342543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
    Goodwin AK; Brown PR; Jansen EE; Jakobs C; Gibson KM; Weerts EM
    Psychopharmacology (Berl); 2009 Jun; 204(3):465-76. PubMed ID: 19198808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex.
    Busardò FP; Gottardi M; Tini A; Minutillo A; Sirignano A; Marinelli E; Zaami S
    Curr Drug Metab; 2018; 19(13):1080-1085. PubMed ID: 30251602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
    Palmer RB
    Toxicol Rev; 2004; 23(1):21-31. PubMed ID: 15298490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL): analysis of overdose cases reported to the Swiss Toxicological Information Centre.
    Liechti ME; Kupferschmidt H
    Swiss Med Wkly; 2004 Sep; 134(35-36):534-7. PubMed ID: 15517507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of gamma-hydroxybutyrate (GHB) and its precursors in blood and urine samples: a salting-out approach.
    Kankaanpää A; Liukkonen R; Ariniemi K
    Forensic Sci Int; 2007 Aug; 170(2-3):133-8. PubMed ID: 17658710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and its metabolic precursor, gamma-butyrolactone (GBL) in rats.
    Baker LE; Van Tilburg TJ; Brandt AE; Poling A
    Psychopharmacology (Berl); 2005 Sep; 181(3):458-66. PubMed ID: 16001124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.